Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Lysosome-targeted NIR-absorbing β-α-α-β-triBODIPY nano-platform for synergistic photothermal-photodynamic therapy.

Created on 09 Nov 2026

Authors

Junjie Liu, Huiquan Zuo, Guoyu Zhang, Qing Wang, Xing Guo, Heng Li, Shaozhen Wang, Lijuan Jiao, Erhong Hao

Published in

Chemical communications (Cambridge, England). Nov 09, 2026. Epub Nov 09, 2026.

Abstract

Phototherapeutic agents that simultaneously integrate near-infrared absorption, combined photothermal/photodynamic therapy, and organelle targeting remain rare. Herein, β-α-α-β-triBODIPYs (BDP1-5) were designed by linking two BODIPY units at the α-positions of a central core. This architecture extended π-conjugation and split the absorption band, with a maximum at ∼780 nm, enabling high photothermal conversion (77.7%) and type I ROS generation. BDP5 NPs achieve lysosomal targeting, realize efficient tumor reduction in vivo, demonstrating integrated PTT/PDT potential.

PMID:
43002174
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement